CME vs TRU

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 21, 2026

CME

50.4
AI Score
VS
TRU Wins

TRU

55.1
AI Score

Investment Advisor Scores

CME

50score
Recommendation
HOLD

TRU

55score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CME TRU Winner
Forward P/E 22.0751 13.1752 TRU
PEG Ratio 4.7381 1.0129 TRU
Revenue Growth 0.8% 14.9% TRU
Earnings Growth 2.5% 32.1% TRU
Tradestie Score 50.4/100 55.1/100 TRU
Profit Margin 63.4% 15.1% CME
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

CME 1M: -5.3% · 3M: +12.1% TRU 1M: -23.0% · 3M: -20.0%

Current Technical Phase

CME

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 42

RSI (14): 41.6 · Price: $263.14

TRU

Markdown
Sell / avoid

Price below a falling SMA50 (slope -2.0%), weak momentum, RSI 30

RSI (14): 29.5 · Price: $63.44

Fundamentals Snapshot

Metric CME TRU
Market Cap — —
Forward P/E 20.4 11.4
Trailing P/E 22.2 16.4
Revenue (TTM) — —
Revenue Growth 0.0% 0.1%
Gross Margin 1.0% 0.6%
Operating Margin 0.7% 0.2%
EPS 11.93 3.79
Dividend Yield 0.02% 0.00%

Frequently Asked Questions

Based on our detailed analysis, TRU is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.